DMEMEDS shared post via Reuters: Novartis skin cancer drug shrinks tumors in Phase II trial

ZURICH (Reuters) - An experimental drug from Novartis markedly shrank tumors in patients with advanced basal cell carcinoma, the most common form of skin cancer, according to the results of a mid-stage study published on Sunday. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/8Pyp4Znp08k/story01.htm

Read More